Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.
Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA. Brunet JS, et al. Among authors: futreal pa. J Natl Cancer Inst. 1998 May 20;90(10):761-6. doi: 10.1093/jnci/90.10.761. J Natl Cancer Inst. 1998. PMID: 9605646
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA. Phelan CM, et al. Among authors: futreal pa. Nat Genet. 1996 May;13(1):120-2. doi: 10.1038/ng0596-120. Nat Genet. 1996. PMID: 8673090
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Futreal PA, Peto J, Stoppa-Lyonnet D, Bignon YJ, Stratton MR. Lakhani SR, et al. Among authors: futreal pa. Clin Cancer Res. 2000 Mar;6(3):782-9. Clin Cancer Res. 2000. PMID: 10741697
Cell cycle control of BRCA2.
Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD. Vaughn JP, et al. Among authors: futreal pa. Cancer Res. 1996 Oct 15;56(20):4590-4. Cancer Res. 1996. PMID: 8840967
BRCA2 mutations in primary breast and ovarian cancers.
Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: futreal pa. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235
Testing for hereditary breast and ovarian cancer in the southeastern United States.
Miron A, Schildkraut JM, Rimer BK, Winer EP, Sugg Skinner C, Futreal PA, Culler D, Calingaert B, Clark S, Kelly Marcom P, Iglehart JD. Miron A, et al. Among authors: futreal pa. Ann Surg. 2000 May;231(5):624-34. doi: 10.1097/00000658-200005000-00002. Ann Surg. 2000. PMID: 10767783 Free PMC article. Clinical Trial.
352 results